ACTRN12614000277640已完成未知
Role of Testosterone in Prevention of Alzheimer’s Disease
McCusker Alzheimer's Research Foundation0 个研究点目标入组 44 人开始时间: 2014年3月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 44
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 50 Years 至 75 Years（—）
- 性别
- Male
入选标准
- •Male participants: needed to 1) be 50 years of age or older, and have 2) a memory complaint, 3) testosterone levels between 300-600 ng/dL (~10.4 - 20.8 nmol/L), 4) normal levels of PSA, 5) blood pressure within normal limits, 6) no signs of diabetes mellitus, 7) normal liver and kidney enzyme function, and 8) No history of major head injury.
- •The diagnosis of subjective memory loss (complaint of memory loss but not meeting the criteria for dementia) was reached after a full clinical evaluation including a review of medical and drug history and a physical examination.
排除标准
- •Any participants meeting the criteria for Dementia were excluded from the study.
研究者
相似试验
尚未招募
1 期
Testosterone to treat men with mild to moderate Crohn's diseaseCrohn's DiseaseACTRN12620000338965Fiona Stanley Hospital46
进行中（未招募）
不适用
Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health OutcomesGenetic DisorderHematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmAnxiety DisorderDepressionNCT04743466M.D. Anderson Cancer Center1
已完成
不适用
Testosterone, aging and cognitive functioningISRCTN42645787Erasmus Medical Centre (The Netherlands)200
已完成
2 期
Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.HypogonadismSarcopeniaDiabetesOsteoporosisDepressionNCT00104572National Institute on Aging (NIA)44
已完成
不适用
Testosterone, aging and cognitive functioning.BPH or fertility problemsNL-OMON28384one200